“…Finally, Pérez-Neri and colleagues analyzed the therapeutic potential of low-intensity, high-intensity focused ultrasound neuromodulation for the management of neuropathic pain, which is especially useful in a group of chronic pain syndromes with a restricted response to conventional drugs [ 8 ]. The information presented is relevant, as it shows that low-intensity focused ultrasound may modify some mechanisms involved in neuropathic pain processes such as modulation of ion channels, glutamatergic neurotransmission, cerebral blood flow, inflammation and neurotoxicity, neuronal morphology and survival, nerve regeneration and remyelination, as well as minor side effects [ 9 ]. The authors propose that more clinical trials on safety and efficacy are needed, despite the evidence provided on the potential therapeutic use of low-intensity, high-intensity focused ultrasound for the management of neuropathic pain.…”